A detailed history of Td Asset Management Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Td Asset Management Inc holds 116,192 shares of LEGN stock, worth $3.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
116,192
Previous 140,992 17.59%
Holding current value
$3.96 Million
Previous $6.24 Million 9.32%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$43.55 - $59.88 $1.08 Million - $1.49 Million
-24,800 Reduced 17.59%
116,192 $5.66 Million
Q2 2024

Aug 02, 2024

SELL
$39.5 - $57.22 $1.79 Million - $2.6 Million
-45,400 Reduced 24.36%
140,992 $6.24 Million
Q1 2024

May 08, 2024

SELL
$55.06 - $69.99 $2.85 Million - $3.63 Million
-51,824 Reduced 21.76%
186,392 $10.5 Million
Q4 2023

Feb 12, 2024

SELL
$57.25 - $69.74 $1.91 Million - $2.33 Million
-33,344 Reduced 12.28%
238,216 $14.3 Million
Q3 2023

Oct 27, 2023

BUY
$63.16 - $76.5 $8.58 Million - $10.4 Million
135,854 Added 100.11%
271,560 $18.2 Million
Q2 2023

Aug 09, 2023

BUY
$46.28 - $75.01 $3.06 Million - $4.96 Million
66,094 Added 94.95%
135,706 $9.37 Million
Q1 2023

May 10, 2023

BUY
$43.42 - $57.37 $1.04 Million - $1.37 Million
23,900 Added 52.28%
69,612 $3.36 Million
Q3 2022

Nov 07, 2022

BUY
$38.15 - $57.1 $437,237 - $654,423
11,461 Added 33.46%
45,712 $1.83 Million
Q2 2022

Aug 04, 2022

BUY
$33.54 - $55.0 $1.15 Million - $1.88 Million
34,251 New
34,251 $1.88 Million
Q1 2021

May 14, 2021

SELL
$23.55 - $32.4 $379,790 - $522,514
-16,127 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$25.8 - $32.39 $41,280 - $51,824
1,600 Added 11.01%
16,127 $454,000
Q3 2020

Nov 10, 2020

SELL
$27.5 - $39.61 $62,287 - $89,716
-2,265 Reduced 13.49%
14,527 $448,000
Q2 2020

Aug 13, 2020

BUY
$36.1 - $42.56 $606,191 - $714,667
16,792 New
16,792 $715,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.71B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.